Permian Investment Partners’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,024,030
Closed -$16.9M 19
2022
Q2
$16.9M Sell
2,024,030
-1,461,212
-42% -$20.4M 2.76% 8
2022
Q1
$79.6M Sell
3,485,242
-1,167,000
-25% -$28.5M 9.54% 6
2021
Q4
$128M Buy
4,652,242
+2,300,000
+98% +$61.6M 13.36% 5
2021
Q3
$65.5M Sell
2,352,242
-388,080
-14% -$11M 6.5% 6
2021
Q2
$80.3M Buy
2,740,322
+108,894
+4% +$3.3M 8.31% 6
2021
Q1
$83.5M Sell
2,631,428
-3,083,527
-54% -$90.4M 10.4% 5
2020
Q4
$119M Buy
5,714,955
+566,655
+11% +$10.6M 17.78% 3
2020
Q3
$80M Buy
5,148,300
+775,000
+18% +$13.3M 15.74% 4
2020
Q2
$80M Buy
+4,373,300
New +$77.1M 14.37% 4

Other funds holding BHC

Permian Investment Partners's BHC Position: Q3 2022 in Review

Permian Investment Partners sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 2,024,030 shares — an estimated $16.9M sold.

Permian Investment Partners first reported a position in BHC in Q2 2020 and held it in 9 quarters. The position peaked at $128M in Q4 2021. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

  • Permian Investment Partners reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
  • Permian Investment Partners sold 2,024,030 Bausch Health shares in Q3 2022, an estimated $16.9M.
  • Permian Investment Partners first reported a position in Bausch Health in Q2 2020 and held it in 9 quarters.
  • Permian Investment Partners's Bausch Health position peaked at $128M in Q4 2021.
  • 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on Permian Investment Partners's 13F filing for Q3 2022, filed 14 Nov 2022.